Baldwin Brothers Inc. MA Cuts Stake in Agilent Technologies Inc (NYSE:A)

Baldwin Brothers Inc. MA cut its position in Agilent Technologies Inc (NYSE:A) by 0.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 59,454 shares of the medical research company’s stock after selling 280 shares during the quarter. Baldwin Brothers Inc. MA’s holdings in Agilent Technologies were worth $4,440,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of A. Destination Wealth Management grew its position in shares of Agilent Technologies by 100.0% during the first quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock worth $32,000 after acquiring an additional 200 shares during the last quarter. Financial Gravity Wealth Inc. bought a new position in shares of Agilent Technologies during the 1st quarter valued at about $52,000. NEXT Financial Group Inc boosted its position in shares of Agilent Technologies by 22.0% during the 2nd quarter. NEXT Financial Group Inc now owns 925 shares of the medical research company’s stock valued at $69,000 after purchasing an additional 167 shares in the last quarter. Knuff & Co LLC boosted its position in shares of Agilent Technologies by 203.3% during the 1st quarter. Knuff & Co LLC now owns 910 shares of the medical research company’s stock valued at $73,000 after purchasing an additional 610 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its position in shares of Agilent Technologies by 36.3% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,193 shares of the medical research company’s stock valued at $96,000 after purchasing an additional 318 shares in the last quarter.

A has been the subject of a number of analyst reports. Needham & Company LLC upped their price objective on shares of Agilent Technologies to $92.00 and gave the company a “buy” rating in a research note on Monday. Bank of America lowered shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price objective for the company. in a research note on Tuesday, July 16th. Deutsche Bank reduced their price objective on shares of Agilent Technologies from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. Wolfe Research started coverage on shares of Agilent Technologies in a research note on Thursday, May 30th. They set a “peer perform” rating for the company. Finally, Piper Jaffray Companies increased their price target on shares of Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, August 15th. Six investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Agilent Technologies has an average rating of “Buy” and a consensus price target of $84.77.

A stock traded down $0.46 during midday trading on Thursday, reaching $71.74. The stock had a trading volume of 1,302,557 shares, compared to its average volume of 2,328,189. The firm has a market cap of $22.67 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 1.98 and a beta of 1.41. Agilent Technologies Inc has a twelve month low of $61.01 and a twelve month high of $82.27. The business has a fifty day simple moving average of $70.35 and a two-hundred day simple moving average of $74.50. The company has a quick ratio of 1.72, a current ratio of 2.13 and a debt-to-equity ratio of 0.27.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 14th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.04. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.24 billion. During the same period in the previous year, the company earned $0.67 EPS. The company’s revenue for the quarter was up 5.6% compared to the same quarter last year. On average, equities analysts predict that Agilent Technologies Inc will post 3.08 earnings per share for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: What is the Ex-Dividend Date in Investing?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.